• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Beclometasone dipropionate/formoterol maintenance and reliever therapy asthma exacerbation benefit increases with blood eosinophil level.

作者信息

Brusselle Guy, Nicolini Gabriele, Santoro Luigi, Guastalla Daniele, Papi Alberto

机构信息

Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.

Chiesi Farmaceutici SpA, Parma, Italy.

出版信息

Eur Respir J. 2021 Jul 8;58(1). doi: 10.1183/13993003.040982020. Print 2021 Jul.

DOI:10.1183/13993003.040982020
PMID:33737409
Abstract
摘要

相似文献

1
Beclometasone dipropionate/formoterol maintenance and reliever therapy asthma exacerbation benefit increases with blood eosinophil level.丙酸倍氯米松/福莫特罗维持和缓解疗法对哮喘急性加重的益处随血液嗜酸性粒细胞水平升高而增加。
Eur Respir J. 2021 Jul 8;58(1). doi: 10.1183/13993003.040982020. Print 2021 Jul.
2
Budesonide-formoterol reliever therapy in intermittent mild persistent asthma.布地奈德-福莫特罗缓解治疗间歇性轻度持续性哮喘
Eur Respir J. 2021 Feb 17;57(2). doi: 10.1183/13993003.03064-2020. Print 2021 Feb.
3
ICS/formoterol maintenance and reliever therapy: how far beyond asthma?吸入性糖皮质激素/福莫特罗维持与缓解治疗：其应用范围能超出哮喘多远？
Thorax. 2023 May;78(5):430-431. doi: 10.1136/thorax-2022-219979. Epub 2023 Mar 2.
4
ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma.成人哮喘的吸入性糖皮质激素-福莫特罗缓解药物逐步治疗算法
Eur Respir J. 2020 Jan 9;55(1). doi: 10.1183/13993003.01407-2019. Print 2020 Jan.
5
Satisfaction with single maintenance and reliever therapy or as-needed combined inhaled corticosteroid-formoterol in adults with asthma.成人哮喘患者对单一维持和缓解治疗或按需联合吸入糖皮质激素-福莫特罗治疗的满意度。
J Allergy Clin Immunol Pract. 2023 Mar;11(3):952-954.e1. doi: 10.1016/j.jaip.2022.11.024. Epub 2022 Dec 5.
6
A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma.呼吁美国加快在哮喘治疗中使用缓解型吸入性糖皮质激素-福莫特罗联合吸入器的实施。
Am J Respir Crit Care Med. 2023 Feb 15;207(4):390-405. doi: 10.1164/rccm.202209-1729PP.
7
Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.布地奈德/福莫特罗维持与缓解治疗中重度哮喘：对嗜酸性气道炎症的影响
Allergy Asthma Proc. 2014 Mar-Apr;35(2):141-7. doi: 10.2500/aap.2014.35.3729.
8
Can single-inhaler Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium therapy postpone or save biologics for severe asthma?丙酸倍氯米松/富马酸福莫特罗/格隆铵单吸入剂治疗能否延缓或避免严重哮喘患者使用生物制剂？
Pulm Pharmacol Ther. 2023 Dec;83:102270. doi: 10.1016/j.pupt.2023.102270. Epub 2023 Nov 24.
9
Budesonide/formoterol as maintenance and reliever therapy compared to fixed-budesonide/formoterol plus albuterol reliever for pediatric asthma: A cost-utility analysis in Colombia.布地奈德/福莫特罗作为维持和缓解治疗与固定剂量布地奈德/福莫特罗加沙丁胺醇缓解剂用于儿童哮喘的比较：哥伦比亚的成本效用分析
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3816-3818.e2. doi: 10.1016/j.jaip.2021.05.023. Epub 2021 Jun 6.
10
Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives.吸入用丙酸倍氯米松/福莫特罗超细颗粒固定复方制剂治疗哮喘：证据与未来展望。
Expert Opin Pharmacother. 2008 Feb;9(3):479-90. doi: 10.1517/14656566.9.3.479.

引用本文的文献

1
Protocol for the INFORM ASTHMA Trial: budesonide-formoterol reliever in adults with asthma on maintenance inhaled corticosteroid.INFORM哮喘试验方案：布地奈德-福莫特罗用于接受维持吸入性糖皮质激素治疗的成年哮喘患者的缓解剂
ERJ Open Res. 2025 Jul 7;11(4). doi: 10.1183/23120541.01208-2024. eCollection 2025 Jul.
2
Effectiveness of Threshold-Pressure Inspiratory Muscle Training on Pulmonary Rehabilitation in Children and Adolescents with Asthma.阈压吸气肌训练对儿童及青少年哮喘患者肺康复的有效性
J Asthma Allergy. 2024 Oct 29;17:1073-1082. doi: 10.2147/JAA.S479398. eCollection 2024.
3
The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthma.
ICS/福莫特罗维持缓解治疗在重度哮喘中的证据基础。
Eur Respir J. 2024 Jun 20;63(6). doi: 10.1183/13993003.00523-2024. Print 2024 Jun.
4
"As-Needed" Inhaled Corticosteroids for Patients With Asthma.按需使用吸入性皮质类固醇治疗哮喘患者。
J Allergy Clin Immunol Pract. 2023 Mar;11(3):726-734. doi: 10.1016/j.jaip.2023.01.010. Epub 2023 Jan 24.
5
Recent insights in the role of biomarkers in severe asthma management.生物标志物在重度哮喘管理中作用的最新见解。
Front Med (Lausanne). 2022 Sep 26;9:992565. doi: 10.3389/fmed.2022.992565. eCollection 2022.
6
Treatment Response Biomarkers in Asthma and COPD.哮喘和慢性阻塞性肺疾病的治疗反应生物标志物
Diagnostics (Basel). 2021 Sep 13;11(9):1668. doi: 10.3390/diagnostics11091668.